Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Corrigendum to “Effect of asta...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Corrigendum to “Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice” [MOLMET 85 (2024) 1–16]

Corrigendum to “Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice” [MOLMET 85 (2024) 1–16]

Bibliographic Details
Main Authors: Joshua Adekunle Babalola, Anika Stracke, Tina Loeffler, Irene Schilcher, Spyridon Sideromenos, Stefanie Flunkert, Joerg Neddens, Ake Lignell, Manuela Prokesch, Ute Panzenboeck, Herbert Strobl, Jelena Tadic, Gerd Leitinger, Achim Lass, Birgit Hutter-Paier, Gerald Hoefler
Format: Article
Language:English
Published: Elsevier 2024-08-01
Series:Molecular Metabolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824001030
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2212877824001030

Similar Items

  • Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice
    by: Joshua Adekunle Babalola, et al.
    Published: (2024-07-01)
  • Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value
    by: Tina Loeffler, et al.
    Published: (2020-06-01)
  • Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy
    by: Sonia Kaniuka-Jakubowska, et al.
    Published: (2018-04-01)
  • Motor deficits and brain pathology in the Parkinson’s disease mouse model hA53Ttg
    by: Livia Breznik, et al.
    Published: (2024-09-01)
  • Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
    by: Joerg Neddens, et al.
    Published: (2020-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs